Jessie Hao-Ru Hsu - Concepedia

Author

Jessie Hao-Ru Hsu

AstraZeneca (United States)

Also Known As

Jessie H. Hsu, Jessie Hao-Ru Hsu, Jessie Hao-ru Hsu, Jessie H. Hsu

Publications

853

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)AstraZeneca (United Kingdom)Dana-Farber Cancer Institute University of Southern California Harvard Stem Cell Institute

About

Jessie Hao-Ru Hsu is an author at AstraZeneca (United States) specializing in cell biology, molecular biology, and chemical biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Cell Biology	3	3	536
2	Medicine	2	2	344
3	Natural Sciences	2	2	47
4	Biochemistry	1	1	20
5	Biomolecular Engineering	1	1	27

Jessie Hao-Ru Hsu

Publications

837

Citations

H-Index

Page 1

	Year	Citations
Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner Huafeng Xie, Jian Xu, Jessie Hao-Ru Hsu, Cell stem cell Cell LineageDevelopmental BiologyDevelopmental-stage-specific MannerMedicineStem Cell Research	2013	317
EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex Jessie Hao-Ru Hsu, Timothy Rasmusson, James Robinson, Cell chemical biology Cell BiologyPrc2 ComplexMolecular Biology	2019	192
BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent of <i>CDKN2A</i> Repression Dorothea Douglas, Jessie Hao-Ru Hsu, Long Hung, Cancer Research	2008	129
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma Adam L. Green, Shakti Ramkissoon, Dilara McCauley, Neuro-Oncology	2014	77
PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer Jessie Hao-Ru Hsu, Benjamin Hubbell-Engler, Guillaume Adelmant, Cancer Research	2017	39
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase Sharan K. Bagal, Clare Gregson, Daniel H. O’Donovan, Journal of Medicinal Chemistry Chemoprevention StrategyEpigenetic ChangeEfficacious InhibitorsMolecular BiologyChemical Biology	2021	27
Ewing Tumors That Do Not Overexpress BMI-1 Are a Distinct Molecular Subclass with Variant Biology: A Report from the Children's Oncology Group Aaron Cooper, John van Doorninck, Lingyun Ji, Clinical Cancer Research	2010	25
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase Daniel H. O’Donovan, Clare Gregson, Martin J. Packer, Bioorganic & Medicinal Chemistry Letters BiochemistryFree Energy PerturbationNatural SciencesCoordination ComplexMolecular Biology	2021	20
Identification of Novel Potent NSD2-PWWP1 Ligands Using Structure-Based Design and Computational Approaches Luca Carlino, Peter C. Astles, Bryony Ackroyd, Journal of Medicinal Chemistry	2024	11

Page 1